Elena Mariggio
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation.
Journal: Journal of clinical medicine
Published: August 11, 2022
MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors.
Journal: Oncology reports
Published: November 30, 2021
Brentuximab vedotin in combination with bendamustine in pediatric patients or young adults with relapsed or refractory Hodgkin lymphoma.
Journal: Pediatric blood & cancer
Published: October 01, 2021
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors.
Journal: Hematological oncology
Published: November 01, 2020
Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 27, 2020
Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients.
Peripherally inserted central catheters in allogeneic hematopoietic stem cell transplant recipients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 15, 2019
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.
Journal: Oncology research and treatment
Published: March 25, 2019
MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
Journal: Frontiers in immunology
Published: December 12, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026